$WT

WT Maintained by Morgan Stanley -- Price Target Lowered to $25

Morgan Stanley maintained an Equal-Weight rating on WisdomTree (WT) but lowered its price target to $25 from $27. GuruFocus values WT at $17.88, suggesting it is 17.8% overvalued. Insider selling and mixed guru activity indicate cautious sentiment. WT has a GF Score of 85/100, reflecting strong performance but valuation concerns.

Original reporting
Published Oct 28, 2026, 6:37 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 28, 2026, 7:56 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$WT
Bearish
high confidence
Mentioned
$WT
Relevance
6/10
AlphAI data visualization · based on gurufocus.com
Decision brief

The 30-second read

$WTBearishMed
01

Why it matters

The price‑target reduction could trigger short‑term downside as traders adjust expectations.

02

Market read

A modest analyst downgrade that may influence short‑term price action but has limited broader market impact.

03

What to watch

The cut does not address underlying fundamentals such as revenue growth or product pipeline.

Relevance 6/10Novelty 6/10Timing: today

Background

WisdomTree is a $3.2 B asset‑manager with a mixed valuation profile; the analyst maintains an Equal‑Weight rating.

Company-level read

Ticker impact

$WTBearishHigh confidence
Context

Morgan Stanley lowered WisdomTree's price target to $25, indicating a more cautious outlook.

Expected impact

likely pressure as the market prices in the lower target

Evidence & confidence

The target reduction is a fresh analyst action that can prompt short-term sell interest.

Market effects

May weigh on other asset‑management stocks as analysts reassess valuations.

Limited to U.S. financial services sector.

Low; primarily a company‑specific update.

Counterpoint

Some investors may view the target cut as an overreaction and see buying opportunity.

Key entities

  • Morgan Stanley

    Provided the rating update and target cut.

  • WisdomTree Inc.

    Subject of the analyst rating change.

Related articles

$WTMed

WisdomTree reports $13.5B net inflows, 7th record AUM quarter

WisdomTree (NYSE: WT) reported $168.9B in assets under management (AUM) for Q3, marking its seventh record quarter. The firm saw $1.2B in net inflows for September and $13.5B year-to-date, with UCITS products contributing $700M in September. Fixed income led inflows, while emerging market equity saw outflows. WisdomTree's tokenized AUM grew 65% year-to-date to $1.3B. The company's blended average fee rate was 36 basis points.

$WTMed

WisdomTree (WT) Stock Is Up, What You Need To Know

WisdomTree (WT) stock rose 2.9% after Goldman Sachs increased its price target to $21.30, citing improved earnings and industry outlook. Shares later settled at $24.40, up 1.5% from the previous close. WT has seen volatility, with 11 moves over 5% in the past year. The stock is up 95% YTD, near its 52-week high of $25.04.

$WTMed

WT Maintained by Craig-Hallum -- Price Target Raised to $29.00

Craig-Hallum raised its price target for WisdomTree (WT) to $29.00 from $24.00, maintaining a 'Buy' rating. The stock is currently priced at $24.73, which GuruFocus deems 40.1% overvalued. WT has a GF Score™ of 82/100, showing strong performance but concerns over valuation. Insiders have sold $736,800 in shares recently, with no purchases.

$WTMed

WT Maintained by Goldman Sachs -- Price Target Raised to $21.30

Goldman Sachs maintained a Neutral rating on WisdomTree (WT) but raised its price target to $21.30 from $18.30. GuruFocus values WT at $17.65, suggesting a 41% overvaluation. The company has a GF Score of 82/100, with strong profitability and growth but low valuation metrics. Insiders have sold $736,800 worth of shares in the last three months.

$WTMed

Should You Buy WisdomTree (WT) Stock After Its Latest Crypto Move?

WisdomTree (WT) reported record AUM of $162.9B in Q2 2026, up 30% YoY, with revenue at $177.2M and 40.5% operating margin. The company partnered with MoonPay to integrate its tokenized fund WTGXX, accessing 35M accounts. Despite GAAP losses from debt repurchases, management highlights long-term growth potential in digital assets. WT trades at a forward P/E of 17.30.

$WTMed

WisdomTree Announces Second Quarter 2026 Results

WisdomTree, Inc. (WT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 WisdomTree Announces Second Quarter 2026 Results Record AUM of $162.9 Billion Diluted Earnings Per Share of $0.28; Adjusted Earnings Per Share of $0.31 13% Annualized Organic Flow Growth Rate Operating Margin Expanded by 780 bps Year over Year; or 900 bps, on an Adju